Dr Utkarsh Chris Shukla, MD | |
4901 Lang Ave Ne, Albuquerque, NM 87109-4397 | |
(505) 842-8171 | |
Not Available |
Full Name | Dr Utkarsh Chris Shukla |
---|---|
Gender | Male |
Speciality | Radiology - Radiation Oncology |
Location | 4901 Lang Ave Ne, Albuquerque, New Mexico |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1437656154 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0001X | Radiology - Radiation Oncology | MD2023-0189 (New Mexico) | Primary |
Entity Name | New Mexico Oncology Hematology Consultants Ltd |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1164475232 PECOS PAC ID: 3577533447 Enrollment ID: O20040728000867 |
News Archive
"A star-studded array of political and religious leaders - from President Obama to rock legend Bono to AIDS activist Kay Warren - came together Thursday for World AIDS Day to call for an entirely AIDS-free generation by 2015," the Washington Post reports.
By injecting quantum dots into tumors, investigators at Carnegie Mellon University have been able to image sentinel lymph nodes in animals using near-infrared light. These results could lead to a simple, non-invasive method for detecting metastasis.
A team of British scientists at Manchester and Lancaster Universities has turned established thinking on its head in a bid to understand the serious and often deadly condition, hydrocephalus, commonly known as 'water on the brain'.
Metabolic surgery patients with a history of coronary artery disease were about two times less likely to have a recurrent and fatal heart attack or develop systolic heart failure compared to closely matched patients who did not have the surgery, according to a new study from Cleveland Clinic Florida researchers who presented their findings today at the 36th American Society for Metabolic and Bariatric Surgery Annual Meeting at ObesityWeek 2019.
Small pieces of nucleic acid, known as siRNAs (short interfering RNAs), can turn off the production of specific proteins, a property that makes them one of the more promising new classes of anticancer drugs in development. Indeed, at least two siRNA-based anticancer therapies, both delivered to tumors in nanoparticles, have begun human clinical trials. Now, three new reports highlight the progress that researchers are making in developing broadly applicable, nanoparticle-enabled siRNA anticancer therapeutics.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Utkarsh Chris Shukla, MD 480 Main St Apt 426, Malden, MA 02148-5142 Ph: () - | Dr Utkarsh Chris Shukla, MD 4901 Lang Ave Ne, Albuquerque, NM 87109-4397 Ph: (505) 842-8171 |
News Archive
"A star-studded array of political and religious leaders - from President Obama to rock legend Bono to AIDS activist Kay Warren - came together Thursday for World AIDS Day to call for an entirely AIDS-free generation by 2015," the Washington Post reports.
By injecting quantum dots into tumors, investigators at Carnegie Mellon University have been able to image sentinel lymph nodes in animals using near-infrared light. These results could lead to a simple, non-invasive method for detecting metastasis.
A team of British scientists at Manchester and Lancaster Universities has turned established thinking on its head in a bid to understand the serious and often deadly condition, hydrocephalus, commonly known as 'water on the brain'.
Metabolic surgery patients with a history of coronary artery disease were about two times less likely to have a recurrent and fatal heart attack or develop systolic heart failure compared to closely matched patients who did not have the surgery, according to a new study from Cleveland Clinic Florida researchers who presented their findings today at the 36th American Society for Metabolic and Bariatric Surgery Annual Meeting at ObesityWeek 2019.
Small pieces of nucleic acid, known as siRNAs (short interfering RNAs), can turn off the production of specific proteins, a property that makes them one of the more promising new classes of anticancer drugs in development. Indeed, at least two siRNA-based anticancer therapies, both delivered to tumors in nanoparticles, have begun human clinical trials. Now, three new reports highlight the progress that researchers are making in developing broadly applicable, nanoparticle-enabled siRNA anticancer therapeutics.
› Verified 5 days ago
Mark Ehrhart, MD Radiology Medicare: Medicare Enrolled Practice Location: Msc 10 5550, 1 University Of New Mexico, Albuquerque, NM 87131 Phone: 505-272-4661 | |
Dr. Shaya Ansari, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 8020 Constitution Pl Ne Ste 202, Albuquerque, NM 87110 Phone: 505-998-3096 Fax: 505-998-3100 | |
Dr. Karen Renee Craig, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2211 Lomas Blvd Ne, Albuquerque, NM 87106 Phone: 505-272-0011 | |
Erika Jane Starks, MD, PHD Radiology Medicare: Medicare Enrolled Practice Location: Radiology Msc 10-5530 1 University Of New Mexico, Albuquerque, NM 87131 Phone: 505-272-6225 | |
Stuart Bernard Paster, Radiology Medicare: Not Enrolled in Medicare Practice Location: 8020 Constitution Place Ne, #101, Albuquerque, NM 87110 Phone: 505-998-1317 Fax: 505-998-1308 | |
Danielle Eckart Sorte, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: Dept Of Radiology Msc 10 5530, 1 University Of New Mexico, Albuquerque, NM 87131 Phone: 801-641-5515 | |
Dr. Luis Centenera, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4411 The 25 Way Ne, Suite 150, Albuquerque, NM 87109 Phone: 505-332-5800 Fax: 505-332-6919 |